ST. PAUL, Minn., June 28, 2012 /PRNewswire/ -- "This is very good news for consumers, and as a company charged with helping our clients secure affordable medicine for customers, we are prepared to ensure a cost-effective, efficient individual market offering," said Eric Elliott, president and CEO of pharmacy benefit manager Prime Therapeutics. "Prime has spent the past two years preparing for the introduction of state-based health care exchanges and other PPACA provisions, and is encouraged by an outcome that supports these efforts and allows us to continue in executing on our strategy."
Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and customers. Providing pharmacy benefit services nationwide to nearly 20 million lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com. Follow Prime on Twitter @Prime_PBM.
SOURCE Prime Therapeutics